What's new

Antimicrobial Sales and Use (ASU) Platform: Release notes

Antimicrobial Sales and Use (ASU) Platform: Release notes

Jun 18, 2025 - 15:05
 0
Antimicrobial Sales and Use (ASU) Platform: Release notes
Read More

Tags:

Previous Article

Concept paper on the new reflection paper on the clinical investigation of medic...

Next Article

Tech-backed nuclear groups raise $1bn as investors bet on power-hungry AI

Related Posts

Human medicines European public assessment report (EPAR): Spevigo, spesolimab, Date of authorisation: 09/12/2022, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 16, 2025  0

EMEA-002736-PIP02-23

EMEA-002736-PIP02-23

Jun 6, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Spevigo, Spesolimab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Skin and subcutaneous tissue disorders, PIP number: P/0157/2024

Opinion/decision on a Paediatric investigation plan (PI...

Jun 6, 2025  0